Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check5 days agoChange DetectedNo changes were provided to add or remove content on this page.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0. This appears to be an administrative site update and does not modify study content or critical information.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated to v3.5.0 with v3.4.3 removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2. This change does not affect study data or page content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page layout has been updated with minor text changes; core study details such as eligibility criteria, interventions, and outcomes remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.